Medinice S.A.

Warsaw Stock Exchange ICE.WA

Medinice S.A. Cash and Short-Term Investments for the year ending December 31, 2023: USD 2.62 M

Medinice S.A. Cash and Short-Term Investments is USD 2.62 M for the year ending December 31, 2023, a -45.86% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Medinice S.A. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 4.84 M, a -38.91% change year over year.
Medinice S.A. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 7.92 M, a 155.77% change year over year.
Medinice S.A. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 3.09 M, a 113.37% change year over year.
Medinice S.A. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 1.45 M, a 53.43% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Warsaw Stock Exchange: ICE.WA

Medinice S.A.

CEO	Mr. Sanjeev Choudhary
IPO Date	Sept. 1, 2018
Location	Poland
Headquarters	ul. Chmielna 132/134
Employees	16
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Clinical Trials Pharmaceuticals

Description

Medinice S.A. provides medical solution for cardiology and cardiac surgery. The company support scientists for product commercialization including prototyping, clinical trials and certification, and product sales. Medinice S.A. was founded in 2012 and is based in Warsaw, Poland.

Key trends

Past 5 years